Community Health Center Drug Pricing Protection Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 59
- Latest action
- Feb 5, 2026
What it does
This bill would require drug manufacturers to sell certain outpatient drugs to Federally-qualified health centers (FQHCs) at the government-negotiated 340B ceiling price at the time of purchase, rather than making them pay more upfront and get a rebate later.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Loading recorded actions…
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
- Jack Bergman
- Adelita Grijalva
- Austin Scott
- Becca Balint
- Bill Huizenga
- Carol Miller
- Celeste Maloy
- Cleo Fields
- David Rouzer
- David Taylor
- Derek Schmidt
- Derrick Van Orden
- Dina Titus
- Donald Davis
- Ed Case
- Eleanor Norton
- Emanuel Cleaver
- Eugene Vindman
- Frank Lucas
- Frank Mrvan
- Gabriel (Gabe) Vasquez
- Gilbert Cisneros
- Gregorio Casar
- Harold Rogers
- Jahana Hayes
- Jake Auchincloss
- Jason Crow
- Jeff Crank
- Jill Tokuda
- Joe Neguse
- Jonathan Jackson
- Josh Riley
- Lloyd Smucker
- Lois Frankel
- Madeleine Dean
- Marie Gluesenkamp Perez
- Mark Amodei
- Mónica De La Cruz
- Nicholas Begich
- Nicole (Nikki) Budzinski
- Paul Tonko
- Raja Krishnamoorthi
- Rashida Tlaib
- Raul Ruiz
- Rick Larsen
- Ritchie Torres
- Robert Bresnahan
- Sanford Bishop
- Sarah McBride
- Seth Moulton
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.